Knobias Clip Report (03-11-2008)
Submitted By Knobias ClipReportSPPI: Management Discusses FDA Approval of Levoleucovorin for InjectionSpectrum Pharmaceuticals, Inc. (SPPI) conducted a conference call after the bell on Monday to discuss the FDA’s approval of Levoleucovorin for Injection. It is indicated after high-dose methotrexate therapy in patients with osteosarcoma, and to diminish the toxicity and counteract the effects of impaired […]
More: continued here